Eli Lilly and Company (LLY)
Market Closed
20 Oct, 08:00 PM
$
1,283. 66
+43.32
+3.4926%
$
1.11T Market Cap
104.2 P/E Ratio
0.05% Div Yield
2.96M Volume
6.64 Eps
$ 1,240.34
Previous Close 
Want to track LLY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pharma Stocks Outlook: Where Are 2024's Top Performers Headed Next?
The three top performing stocks discussed below have appreciated in value by an average of 129.7% in 2024. Such torrid growth logically raises the question of what is possible moving forward.
Investorplace | 2 years ago
Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
Eli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their primary endpoint of non-inferior reduction in blood sugar levels compared with daily basal insulins.
Zacks | 2 years ago
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks | 2 years ago
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Here we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK), that have raised their earnings as well as sales guidance for 2024.
Zacks | 2 years ago
2026 © Marketlog. All Rights Reserved.
